WF2304-A172401: Complementary Options for Symptom Management In Cancer (COSMIC): Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics
About
The objective of this study is to examine the association between cannabis and/or cannabinoid use and cancer-related symptoms assessed monthly for 1 year in adults newly diagnosed with breast, colorectal, melanoma, non-Hodgkin lymphoma or non-small cell lung cancer who are planning or recently started to receive 1 or more systemic cancer directed therapies with chemotherapy and/or immune check point inhibitors (ICIs) targeting PD-1, PD-L1 or CTLA-4.
Eligibility Criteria
Inclusion Criteria
- Adults aged 18 years or older with one of the following newly diagnosed cancers: breast cancer, colorectal cancer, melanoma, non-Hodgkin lymphoma or non-small cell lung cancer.
- Planned treatment with systemic chemotherapy (single or multi-agent, includes targeted therapy) and/or immune checkpoint inhibitor therapy (targeting PD-1, PD-L1 or CTLA-4). If unable to engage participant before treatment starts, enrollment is allowed up to the start of Cycle 2 treatment.
- Participants must be able to comprehend English or Spanish (for survey completion).
- Participant must have a working email address and be willing to complete surveys online. This can be completed at home, in the clinic or other location.
Exclusion Criteria
- Currently enrolled in an interventional supportive treatment trial to manage cancer symptoms.
- Participants with known pregnancy.
Primary Investigator
Terry Paul Nickerson, MD, is a board-certified colon and rectal surgeon. He completed his general surgery residency and colon and rectal surgery fellowship at the Mayo Clinic in Rochester, Minnesota. After finishing his fellowship, Dr. Nickerson worked at MD Anderson Cancer Center, an NCI-designated Comprehensive Cancer Center in Houston, TX. In 2019, he joined the Department of General Surgery at Carilion Clinic as a colon and rectal surgeon. Dr. Nickerson is also an associate professor at the Virginia Tech Carilion School of Medicine.
Contact Information
Bailey Steele, MPH
Clinical Research Coordinator
